Metro Healthcare Indonesia Stock Price To Earning
| CARE Stock | IDR 170.00 5.00 3.03% |
Metro Healthcare Indonesia fundamentals help investors to digest information that contributes to Metro Healthcare's financial success or failures. It also enables traders to predict the movement of Metro Stock. The fundamental analysis module provides a way to measure Metro Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Metro Healthcare stock.
Metro |
Metro Healthcare Indonesia Company Price To Earning Analysis
Metro Healthcare's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Metro Healthcare Indonesia has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. The price to earning for all Indonesia stocks is 100.0% higher than that of the company.
Metro Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Metro Healthcare's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Metro Healthcare could also be used in its relative valuation, which is a method of valuing Metro Healthcare by comparing valuation metrics of similar companies.Metro Healthcare is currently under evaluation in price to earning category among its peers.
Metro Fundamentals
| Return On Equity | -0.0284 | |||
| Return On Asset | -0.0089 | |||
| Profit Margin | (0.40) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 14.97 T | |||
| Shares Outstanding | 33.25 B | |||
| Shares Owned By Insiders | 57.75 % | |||
| Shares Owned By Institutions | 21.46 % | |||
| Price To Book | 4.73 X | |||
| Price To Sales | 64.43 X | |||
| Revenue | 290.93 B | |||
| Gross Profit | 144.45 B | |||
| EBITDA | 31.94 B | |||
| Net Income | 6.1 B | |||
| Cash And Equivalents | 1.22 T | |||
| Cash Per Share | 36.68 X | |||
| Total Debt | 177.46 B | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 25.04 X | |||
| Book Value Per Share | 96.76 X | |||
| Cash Flow From Operations | 47.13 B | |||
| Earnings Per Share | 0.67 X | |||
| Number Of Employees | 1.03 K | |||
| Beta | -0.15 | |||
| Market Capitalization | 15.56 T | |||
| Total Asset | 4.21 T | |||
| Z Score | 52.2 | |||
| Net Asset | 4.21 T |
About Metro Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Metro Healthcare Indonesia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Metro Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Metro Healthcare Indonesia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Metro Stock
Metro Healthcare financial ratios help investors to determine whether Metro Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metro with respect to the benefits of owning Metro Healthcare security.